Arginine-specific gingipains from Porphyromonas gingivalis stimulate production of hepatocyte growth factor (scatter factor) through protease-activated receptors in human gingival fibroblasts in culture.
Cystein proteinases (gingipains) from Porphyromonas gingivalis cleave a broad range of in-host proteins and are considered to be key virulence factors in the onset and development of adult periodontitis and host defense evasion. In periodontitis, an inflammatory disease triggered by bacterial infection, the production of hepatocyte growth factor (HGF) is induced not only by various factors derived from the host, such as inflammatory cytokines, but also by bacterial components. In this study we examined the possible enhanced production of HGF produced by human gingival fibroblasts upon stimulation with gingipains. Arginine-specific gingipain (Rgp) caused a marked production of HGF into the supernatant, the induction of HGF expression on the cell surface, and the up-regulation of HGF mRNA expression in a dose-dependent and an enzymatic activity-dependent manner. Because it has been reported that Rgp activated protease-activated receptors (PARs), we examined whether the induction of HGF triggered by Rgps on human gingival fibroblasts occurred through PARs. An RNA interference assay targeted to PAR-1 and PAR-2 mRNA revealed that gingipains-induced secretion of HGF was significantly inhibited by RNA interference targeted to PAR-1 and PAR-2. In addition, the Rgps-mediated HGF induction was completely inhibited by the inhibition of phospholipase C and was clearly inhibited by RNA interference targeted to p65, which is an NF-kappaB component. These results suggest that Rgps activated human gingival fibroblasts to secrete HGF in the inflamed sites and the mechanism(s) involved may actively participate in both inflammatory and reparative processes in periodontal diseases.
Uehara
Akiko
A
Department of Microbiology and Immunology, Tohoku University Graduate School of Dentistry, Sendai, Japan. kyoro@mail.tains.tohoku.ac.jp
Muramoto
Koji
K
Imamura
Takahisa
T
Nakayama
Koji
K
Potempa
Jan
J
Travis
James
J
Sugawara
Shunji
S
Takada
Haruhiko
H
D018829:Adhesins, Bacterial / Q000494:pharmacology*; D000590:Amino Acid Chloromethyl Ketones / Q000494:pharmacology; D002478:Cells, Cultured; D003546:Cysteine Endopeptidases / Q000494:pharmacology*; D005347:Fibroblasts / Q000378:metabolism; D000080867:Gingipain Cysteine Endopeptidases; D005881:Gingiva / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D017228:Hepatocyte Growth Factor / Q000096:biosynthesis*; D006801:Humans; D016328:NF-kappa B / Q000502:physiology; D010518:Periodontitis / Q000209:etiology; D044463:Receptor, PAR-1 / Q000502:physiology*; D044464:Receptor, PAR-2 / Q000502:physiology*; D010738:Type C Phospholipases / Q000502:physiology
D018829:Adhesins, Bacterial; D000590:Amino Acid Chloromethyl Ketones; D000080867:Gingipain Cysteine Endopeptidases; D016328:NF-kappa B; D044463:Receptor, PAR-1; D044464:Receptor, PAR-2; D017228:Hepatocyte Growth Factor; D010738:Type C Phospholipases; D003546:Cysteine Endopeptidases; C040308:phenylalanyl-prolyl-arginine-chloromethyl ketone